Treatment with vigabatrin carries the risk of permanent vision loss. The Food and Drug Administration (FDA) has expanded the approval of Sabril® (vigabatrin; Lundbeck) to include treatment of ...
The FDA has approved Stavzor (valproic acid delayed-release capsules, from Noven) for the treatment of manic episodes in bipolar disorder, complex partial seizures, and migraine prophylaxis. Stavzor’s ...
According to the Centers for Disease Control and Prevention (CDC), about 1 out of 10 people will have a seizure during their lifetime. Most of these seizures will be epileptic seizures, which are ...
Am J Health Syst Pharm. 2009;66(6):541-561. Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam ...
Research has shown early diagnosis and treatment of epilepsy disorders can improve outcomes. The question of when to ...
Brain CT shows right temporal lobe epilepsy with hypometabolism. Seizures in the elderly often mimic other conditions, such as transient ischemic attack or dementia. Don't be fooled into a ...
Newspoint on MSN
Understanding epilepsy: Causes, symptoms, and remedies
What is Epilepsy? Epilepsy can arise from various factors, including genetics, head injuries, infections, brain tumors, ...
Epilepsy is the fourth most common neurologic disorder in the United States. Approximately 3.4 million people in the United States have epilepsy. 1 An estimated 1 in 26 people will develop epilepsy in ...
Epilepsy surgery has been shown to be an effective treatment for patients with intractable epilepsy. The only randomized controlled trial conducted in this setting to date found a dramatic advantage ...
Epilepsy is relatively common in children. Many children with epilepsy will outgrow the condition before their teens, and, if not, treatments usually ensure a full and healthy life. In this article, ...
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic drug (AED) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results